(FM) Hematología

2019

1. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

   Blood

2. Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role (Leukemia, (2018), 32, 11, (2427-2434), 10.1038/s41375-018-0072-6)

   Leukemia

3. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

   TH Open

4. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

   Nature Medicine

5. Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study

   British Journal of Haematology

6. Role of urine immunofixation in defining CR in MM

   Blood

7. Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)

   American Journal of Hematology